Lataa...
A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma
Despite numerous clinical trials and pre-clinical developments, the treatment of glioblastoma (GB) remains a challenge. The current survival rate of GB averages one year, even with an optimal standard of care. However, the future promises efficient patient-tailored treatments, including targeted rad...
Tallennettuna:
| Julkaisussa: | Theranostics |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Ivyspring International Publisher
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8315062/ https://ncbi.nlm.nih.gov/pubmed/34335972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.56639 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|